Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With Peritoneal Carcinomatosis
Conditions: Gastric Adenocarcinoma; Gastric Cancer; Esophagogastric Junction; Peritoneal Carcinomatosis Interventions: Drug: Paclitaxel; Drug: Capecitabine; Device: BardPort Titanium Implanted Port withPeritoneal Catheter Sponsor: National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Gastric (Stomach) Cancer | Gastroenterology | Oral Cancer | Peritoneal Cancer | Research | Xeloda